Loading institutional data...
Loading institutional data...
Held by 165 of 5,944 reporting institutions (90th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$5M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -119%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash of $157M fully covers short-term debt of $25M.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $271.1M 100.0% | $452.7M 100.0% | $238.7M 100.0% | $180.4M 100.0% | $121.6M 100.0% | $100.3M 100.0% | $139.4M 100.0% | $104.4M 100.0% | $111.6M 100.0% | $117.7M 100.0% |
| Cost of Revenue | $225.1M 83.0% | $269.8M 59.6% | $181.8M 76.2% | $175.4M 97.2% | $111.7M 91.8% | $85.7M 85.4% | — | — | $92.1M 82.5% | $93.1M 79.1% |
| Cost of Products | — | — | — | — | — | — | — | — | $92.1M 82.5% | $93.1M 79.1% |
| Cost of Services | — | — | — | — | — | — | — | — | $908K 0.8% | $1.3M 1.1% |
| Gross Profit | $46.0M 17.0% | $182.9M 40.4% | $56.9M 23.8% | $5.0M 2.8% | $9.9M 8.2% | $14.6M 14.6% | $26.3M 18.9% | $12.7M 12.1% | $18.7M 16.7% | $23.3M 19.8% |
| Research & Development | $13.4M 4.9% | $18.1M 4.0% | $16.4M 6.9% | $16.9M 9.4% | $11.4M 9.4% | $8.7M 8.7% | $8.4M 6.0% | $6.3M 6.1% | $6.2M 5.5% | $5.3M 4.5% |
| Selling, General & Admin | $55.8M 20.6% | $71.1M 15.7% | $56.8M 23.8% | $38.5M 21.3% | $22.5M 18.5% | $15.7M 15.6% | $16.5M 11.8% | $19.1M 18.3% | $19.0M 17.0% | $17.4M 14.8% |
| Total Operating Expenses | $424.2M 156.5% | $128.4M 28.4% | $106.1M 44.5% | $84.2M 46.7% | $50.5M 41.6% | $36.2M 36.1% | $40.4M 29.0% | $46.6M 44.6% | $37.8M 33.9% | $34.5M 29.3% |
| Operating Income | -$378.2M -139.5% | $54.5M 12.0% | -$49.2M -20.6% | -$79.2M -43.9% | -$40.6M -33.4% | -$21.6M -21.5% | -$14.2M -10.2% | -$33.9M -32.5% | -$19.1M -17.1% | -$11.2M -9.5% |
| Other Income (Expense), net | -$8.9M -3.3% | -$39.4M -8.7% | $3.4M 1.4% | -$3.5M -1.9% | $3.5M 2.9% | -$240K -0.2% | -$406K -0.3% | -$524K -0.5% | -$185K -0.2% | -$803K -0.7% |
| Pretax Income | -$387.2M -142.8% | $15.1M 3.3% | -$45.8M -19.2% | -$82.7M -45.9% | — | — | — | — | — | — |
| Income Tax Expense | $2.4M 0.9% | $1.7M 0.4% | $0 0.0% | $0 0.0% | — | — | — | — | — | — |
| Net Income | -$389.6M -143.7% | $13.4M 3.0% | -$45.8M -19.2% | -$82.7M -45.9% | -$37.1M -30.5% | -$21.8M -21.7% | -$14.6M -10.5% | -$34.4M -33.0% | -$19.3M -17.3% | -$12.0M -10.2% |
| Per Share | ||||||||||
| EPS (Basic) | $-4.73 | $0.17 | $-0.66 | $-2.10 | $-1.22 | $-0.83 | — | — | — | — |
| EPS (Diluted) | $-4.73 | $0.17 | $-0.66 | $-2.10 | $-1.22 | $-0.83 | — | — | — | — |
| Weighted Avg Shares (Basic) | 82.3M | 77.5M | 69.4M | 39.4M | 30.4M | 26.4M | — | — | — | — |
| Weighted Avg Shares (Diluted) | 82.3M | 80.3M | 69.4M | 39.4M | 30.4M | 26.4M | — | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 12-yr range · 54th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 12-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 19.8× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | — | — | 85.4 | 91.8 | 97.2 | 76.2 | 59.6 | 83.0 |
| Gross Profit | 12.1 | 18.9 | 14.6 | 8.2 | 2.8 | 23.8 | 40.4 | 17.0 |
| R&D | 6.1 | 6.0 | 8.7 | 9.4 | 9.4 | 6.9 | 4.0 | 4.9 |
| SG&A | 18.3 | 11.8 | 15.6 | 18.5 | 21.3 | 23.8 | 15.7 | 20.6 |
| Operating Income | -32.5 | -10.2 | -21.5 | -33.4 | -43.9 | -20.6 | 12.0 | -139.5 |
| Income Tax | — | — | — | — | 0.0 | 0.0 | 0.4 | 0.9 |
| Net Income | -33.0 | -10.5 | -21.7 | -30.5 | -45.9 | -19.2 | 3.0 | -143.7 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ASPN: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $29.49T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $371.6B | 42.5× | 29.7× | 5.5× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.8B | 38.5× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $259.8B | 39.0× | 18.5× | 2.9× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $199.4B | 79.4× | 40.2× | 2.2× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $185.4B | 37.1× | — | 4.1× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $177.4B | 47.9× | 31.6× | 5.5× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $167.6B | 23.6× | 16.1× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $158.8B | 39.2× | — | 5.8× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.2B | 28.1× | 16.1× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.2B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $118.7B | 34.1× | 26.8× | 6.0× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.3B | 24.9× | — | 4.9× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $96.2B | 23.0× | 16.9× | 1.8× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.4B | 32.6× | 23.3× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $92.4B | 70.8× | 43.8× | 9.0× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| PWR | $92.2B | 90.7× | 45.8× | 3.2× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| JCI | $91.9B | 28.0× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $90.7B | 60.9× | 39.9× | 11.0× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $87.3B | 27.4× | 16.8× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.0B | 31.8× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $85.0B | 15.3× | 9.5× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $83.0B | 36.5× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $79.8B | 45.0× | 28.7× | 7.7× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| ASPN | $424M | — | — | 1.6× | -40.1% | 17.0% | -144% | -165% | -119% | -0.3× | 165 |
Peers = companies sharing ASPN's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.